Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study.
Journal: Breast cancer research and treatment
Published: November 04, 2025
Pembrolizumab and Paclitaxel in HR+/HER2- Breast Cancer with HER2-Enriched or Basal-Like Subtypes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2025
Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2025
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 27, 2024
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
Journal: NPJ breast cancer
Published: September 28, 2024
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 29, 2024
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Journal: Breast cancer research and treatment
Published: March 01, 2024
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: March 26, 2023
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
Journal: Frontiers in oncology
Published: July 10, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026